All news

McKesson outlines fiscal 2027 adjusted EPS of $45.60-$46.40 and closes $2.25 billion deal

Seeking Alpha · · AI-summarised by FinFlash

McKesson outlined fiscal 2027 adjusted earnings per share of $45.60 to $46.40 while closing its $2.25 billion Precision Medicine Group deal, according to a Seeking Alpha market news item on the drug distributor's outlook. The shares were shown up 6.98% on the feed. The outlook adds to a strong week for healthcare stocks following the Democratic sweep of the US midterm elections.

So What?

The guide and deal add to the bullish case for drug distributors. Watch how quickly the Precision Medicine business contributes to earnings.

Read original source

MCK company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.